Skip to main content
Clinical Trials/NCT00381225
NCT00381225
Withdrawn
Not Applicable

Feasibility of Ultra-sound Guided Radiofrequency Ablation in the Management of Head and Neck Neoplasia.

Johns Hopkins University1 site in 1 countryNovember 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Head and Neck Neoplasia
Sponsor
Johns Hopkins University
Locations
1
Primary Endpoint
Technical success
Status
Withdrawn
Last Updated
8 years ago

Overview

Brief Summary

To study the feasibility of Radiofrequency ablation (RFA) via ultrasound guidance in the management of head and neck neoplasia.

Detailed Description

The study evaluates the feasibility of radio-frequency ablation in the management of head and neck neoplasia.

Registry
clinicaltrials.gov
Start Date
November 2006
End Date
March 18, 2008
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with head and neck neoplasia.

Exclusion Criteria

  • When the patient does not meet the inclusion criteria.
  • When the patient has a contra-indication of surgery or anesthesia.
  • If the patient refuses involvement in the study.

Outcomes

Primary Outcomes

Technical success

Time Frame: Length of the procedure, up to 1 hour

Technical success is defined as the ability to successfully enter the thyroid nodule via ultrasound guidance and apply the RFA. Assessed via surgeon self report

Study Sites (1)

Loading locations...

Similar Trials